YARROW BIOSCIENCE, INC. Payments to Acquire Debt Securities, Available-for-sale
YARROW BIOSCIENCE, INC. (YARW) reported Payments to Acquire Debt Securities, Available-for-sale of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2021-03-04
- YARROW BIOSCIENCE, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2020-12-31 was $0.00.
- YARROW BIOSCIENCE, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2019-12-31 was -$3.04M.
- YARROW BIOSCIENCE, INC. payments to acquire debt securities, available-for-sale for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- YARROW BIOSCIENCE, INC. payments to acquire debt securities, available-for-sale for fiscal 2019 was $44.96M, a 42.10% decline from fiscal 2018.
- YARROW BIOSCIENCE, INC. payments to acquire debt securities, available-for-sale for fiscal 2018 was $77.65M.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $0.00 10-K · filed 2021-03-04 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 | ||
| 2019-12-31 | -$3.04M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $44.96M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $48.00M 10-Q · filed 2020-11-05 | ||
| 2018-12-31 | $77.65M 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |